These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7330117)

  • 1. [Bioavailability of two commercial phenytoin preparations (author's transl)].
    Yahaba Y; Obata N; Hidano F; Hori H; Unno K
    Seishin Shinkeigaku Zasshi; 1981; 83(9):582-96. PubMed ID: 7330117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
    Brandau R; Wehnert HU
    Arzneimittelforschung; 1979; 29(3):552-5. PubMed ID: 582744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bio-availability of phenytoin free-acid serum level determinations whilst using a lactose-based tablet-preparation (author's transl)].
    Fritsch G; Haidvogl M; Füger G; Urban C
    Monatsschr Kinderheilkd; 1980 Oct; 128(10):648-50. PubMed ID: 6107823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of phenytoin: a comparison between two preparations.
    Zylber-Katz E; Granit L; Levy M
    Isr J Med Sci; 1978 Apr; 14(4):489-91. PubMed ID: 352994
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced seizure control due to spoiled phenytoin capsules.
    Cloyd JC; Gumnit RJ; Lesar TS
    Ann Neurol; 1980 Feb; 7(2):191-3. PubMed ID: 7369725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of several phenytoin preparations marketed in Austria.
    Nitsche V; Mascher H; Schütz H
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):104-7. PubMed ID: 6698663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl].
    Tsuruoka M; Hashimoto T; Seo H; Ichimasa S; Ueno O; Fujinaga T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1981 Apr; 101(4):360-7. PubMed ID: 7288580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of phenytoin availability from pharmaceutical preparations].
    Leucuţa SE; Almaşu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):273-82. PubMed ID: 2951832
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bioavailability of three brands of commercial ampicillin (author's transl)].
    Andrade L; Ortiz S; Firmani F; Cid E
    Ann Pharm Fr; 1978; 36(11-12):639-44. PubMed ID: 754644
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
    Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
    J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of two quinidin drug-released products (author's transl)].
    Sado PA; Le Verge R; Devissaguet JP
    Therapie; 1979; 34(6):713-26. PubMed ID: 547445
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size.
    Hamaguchi T; Shinkuma D; Irie T; Yamanaka Y; Morita Y; Iwamoto B; Miyoshi K; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):326-30. PubMed ID: 8370631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenytoin. A comparison of two preparations.
    Stewart MJ; Ballinger BR; Devlin EJ; Miller AY; Ramsay AC
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):209-12. PubMed ID: 1243984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioavailability: concept and problems (author's transl)].
    Balant L
    J Pharm Belg; 1980; 35(5):369-76. PubMed ID: 7452443
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative bioavailability of two oral forms of dihydroergotamine (author's transl)].
    Luccioni F; Kiechel JR
    Therapie; 1979; 34(5):625-34. PubMed ID: 583555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative bioavailability of two forms of spironolactone. Rationalization applied to dosage (author's transl)].
    d'Athis P; Richard MO; de Lauture D; Rey E; Bouvier d'Yvoire M; Clement E; Olive G
    Therapie; 1981; 36(4):443-9. PubMed ID: 7292427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders].
    Wierzchowiecki M; Swiderczuk A; Dyderski S; Masiakowski J; Jazienicki B
    Kardiol Pol; 1987; 30(9):577-82. PubMed ID: 2447321
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability of phenytoin from various pharmaceutical preparations in children.
    Manson JI; Beal SM; Magarey A; Pollard AC; O'Reilly WJ; Sansom LN
    Med J Aust; 1975 Oct; 2(15):590-2. PubMed ID: 1196223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relative bioavailability of phenytoin and barbiturates in single or combined preparations].
    Procaccianti G; Albani F; Riva R; Baruzzi A
    Boll Chim Farm; 1981 Dec; 120(12):725-9. PubMed ID: 7344726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.